These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23235919)

  • 1. Evaluation of sources to document extended shelf lives of compounded cytostatics.
    Larsson I; Kart T
    J Oncol Pharm Pract; 2013 Dec; 19(4):355-64. PubMed ID: 23235919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability issues of parenteral chemotherapy drugs.
    de Lemos ML; Hamata L
    J Oncol Pharm Pract; 2007 Mar; 13(1):27-31. PubMed ID: 17621564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the distribution of batch shelf lives.
    Quinlan M; Stroup W; Christopher D; Schwenke J
    J Biopharm Stat; 2013; 23(4):897-920. PubMed ID: 23786624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxics compounded sterile preparation control by HPLC during a 16-month assessment in a French university hospital: importance of the mixing bags step.
    Castagne V; Habert H; Abbara C; Rudant E; Bonhomme-Faivre L
    J Oncol Pharm Pract; 2011 Sep; 17(3):191-6. PubMed ID: 20630921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy waste reduction through shelf-life extension.
    Walker SE; Iazzetta J; De Angelis C; Gafni A
    Can J Hosp Pharm; 1994 Feb; 47(1):15-23. PubMed ID: 10132674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compounding parenteral nutrition: reducing the risks.
    Curtis C; Sacks GS
    Nutr Clin Pract; 2009; 24(4):441-6. PubMed ID: 19605798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploratory analysis for the implementation of antineoplastic logarithmic dose banding.
    Albert-Marí A; Valero-García S; Fornés-Ferrer V; Poveda-Andrés JL
    Int J Clin Pharm; 2018 Oct; 40(5):1281-1291. PubMed ID: 30097820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalence tests for shelf life and average drug content in stability studies.
    Djira GD; Hothorn LA; Tsong Y
    J Biopharm Stat; 2008; 18(5):985-95. PubMed ID: 18781530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential clinical impact of compounded versus noncompounded intrathecal baclofen.
    Moberg-Wolff E
    Arch Phys Med Rehabil; 2009 Nov; 90(11):1815-20. PubMed ID: 19887203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Current Practices in Shelf Life Estimation.
    Capen R; Christopher D; Forenzo P; Huynh-Ba K; LeBlond D; Liu O; O'Neill J; Patterson N; Quinlan M; Rajagopalan R; Schwenke J; Stroup W
    AAPS PharmSciTech; 2018 Feb; 19(2):668-680. PubMed ID: 28948584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-phase shelf-life estimation.
    Shao J; Chow SC
    Stat Med; 2001 Apr; 20(8):1239-48. PubMed ID: 11304739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability and consistency of compounded oral liquid levothyroxine formulations.
    Meyer LM; Stephens K; Carter CA; Pickard W; Johnson PR; Eagerton DH
    J Am Pharm Assoc (2003); 2020; 60(6):e168-e172. PubMed ID: 32591200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the performance of the ICH guidelines for shelf life estimation.
    Quinlan M; Stroup W; Schwenke J; Christopher D
    J Biopharm Stat; 2013; 23(4):881-96. PubMed ID: 23786363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of risk for sterile preparations.
    ben-Horin SF; Rousso T
    Int J Pharm Compd; 2014; 18(1):30-4. PubMed ID: 24881337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Shelf life and treatment term for pharmacy-compounded preparations].
    Duquet N
    J Pharm Belg; 2010 Mar; (1):19-21. PubMed ID: 20432591
    [No Abstract]   [Full Text] [Related]  

  • 17. Stability analysis with discrete responses.
    Chow SC; Shao J
    J Biopharm Stat; 2003 Aug; 13(3):451-62. PubMed ID: 12921393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical evaluation of compounded trilostane products.
    Cook AK; Nieuwoudt CD; Longhofer SL
    J Am Anim Hosp Assoc; 2012; 48(4):228-33. PubMed ID: 22611212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction bounds for random shelf-lives.
    Shao J; Chen L
    Stat Med; 1997 May; 16(10):1167-73. PubMed ID: 9179981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of commercially manufactured and compounded protamine zinc insulin.
    Scott-Moncrieff JC; Moore GE; Coe J; Lynn RC; Gwin W; Petzold R
    J Am Vet Med Assoc; 2012 Mar; 240(5):600-5. PubMed ID: 22332631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.